Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 3
2004 3
2005 2
2006 10
2007 16
2008 24
2009 34
2010 35
2011 48
2012 49
2013 54
2014 63
2015 58
2016 58
2017 61
2018 81
2019 73
2020 125
2021 113
2022 139
2023 132
2024 59

Text availability

Article attribute

Article type

Publication date

Search Results

1,109 results

Results by year

Filters applied: . Clear all
Page 1
Claudin18.2-targeted cancer theranostics.
Zhang D, Huang G, Liu J, Wei W. Zhang D, et al. Among authors: huang g. Am J Nucl Med Mol Imaging. 2023 Apr 25;13(2):64-69. eCollection 2023. Am J Nucl Med Mol Imaging. 2023. PMID: 37214268 Free PMC article. Review.
ImmunoPET: Concept, Design, and Applications.
Wei W, Rosenkrans ZT, Liu J, Huang G, Luo QY, Cai W. Wei W, et al. Among authors: huang g. Chem Rev. 2020 Apr 22;120(8):3787-3851. doi: 10.1021/acs.chemrev.9b00738. Epub 2020 Mar 23. Chem Rev. 2020. PMID: 32202104 Free PMC article. Review.
GPC3-targeted immunoPET imaging of hepatocellular carcinomas.
An S, Zhang D, Zhang Y, Wang C, Shi L, Wei W, Huang G, Liu J. An S, et al. Among authors: huang g. Eur J Nucl Med Mol Imaging. 2022 Jul;49(8):2682-2692. doi: 10.1007/s00259-022-05723-x. Epub 2022 Feb 11. Eur J Nucl Med Mol Imaging. 2022. PMID: 35147737
ACLY facilitates colon cancer cell metastasis by CTNNB1.
Wen J, Min X, Shen M, Hua Q, Han Y, Zhao L, Liu L, Huang G, Liu J, Zhao X. Wen J, et al. Among authors: huang g. J Exp Clin Cancer Res. 2019 Sep 12;38(1):401. doi: 10.1186/s13046-019-1391-9. J Exp Clin Cancer Res. 2019. PMID: 31511060 Free PMC article.
Targeting the chromatin effector Pygo2 promotes cytotoxic T cell responses and overcomes immunotherapy resistance in prostate cancer.
Zhu Y, Zhao Y, Wen J, Liu S, Huang T, Hatial I, Peng X, Al Janabi H, Huang G, Mittlesteadt J, Cheng M, Bhardwaj A, Ashfeld BL, Kao KR, Maeda DY, Dai X, Wiest O, Blagg BSJ, Lu X, Cheng L, Wan J, Lu X. Zhu Y, et al. Among authors: huang g. Sci Immunol. 2023 Mar 17;8(81):eade4656. doi: 10.1126/sciimmunol.ade4656. Epub 2023 Mar 10. Sci Immunol. 2023. PMID: 36897957 Free PMC article.
1,109 results